
About Encodia
Encodia is a Healthcare company based in San Diego (United States) founded in 2015. Technology platforms for integrative proteomic analysis are developed. Encodia has raised $75 million across 4 funding rounds from investors including ARE, Arch Venture Partners and Deerfield. The company has 85 employees. Encodia offers products and services including ProteoCode. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Proteomics. Its legal entity is ENCODIA, INC. Its competitors include Tierra Biosciences, Amide Technologies and Aquagene; 2 of its 3 listed competitors have raised funding.
Company details
Encodia was founded in 2015 and is based in San Diego, United States. Integrative proteomic analysis is supported through developed technology platforms. Fluidics-based instruments are offered to facilitate automatic multi-step biochemical and chemical processes. Operations focus on the biotechnology sector, with services centered on proteomic tools for research applications. The companys domain is encodia.com.
- Headquarters San Diego, United States
- Employees 85
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website encodia.com
- Social LinkedIn X
- Legal Name Encodia, Inc.
- Total Equity Funding$75M (USD)
in 4 rounds
- Latest Funding Round$75M (USD), Series C
Jan 2021
- InvestorsARE
& 9 more
- Employee Count85
Products & Services of Encodia
Encodia offers a comprehensive portfolio of products and services, including ProteoCode.
Enables scalable NGS-based analysis of protein libraries for health innovations.
Funding Insights of Encodia
Encodia has successfully raised a total of $75M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $75 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $75M
- Total Rounds 4
- Last Round Series C β $75M
- First Round $222,959
(Jun 2018)
- Investors Count 10
All 4 funding rounds of Encodia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $75M | Series C | β | Deerfield, Northpond Ventures | |
| Nov 2018 | Seed | β | Biomatics Capital | β | |
| Jun 2018 | $222,959 | Grant | β | β | |
| Jun 2018 | $718,340 | Grant | β | β |
10 investors in total: 10 institutional.
Investors in Encodia
Encodia has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Arch Venture Partners and Deerfield.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
Corporate backed venture capital fund investing in multiple sectors | gv.com | Mountain View, United States | ||
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
Venture capital firm focused on life science and technology sectors | decheng.com | Shanghai, China | ||
Venture capital firm focused on multiple sectors | taocap.com | Marlborough, United States | ||
Early-stage tech and life sciences focused VC firm investing primarily in the US | biomaticscapital.com | Seattle, United States | ||
Corporate backed venture capital firm investing in life sciences sector | nanfunglifesciences.com | San Francisco, United States | ||
Venture capital firm investing in life sciences & tech sectors | npv.vc | Cambridge, United States | ||
| sbir.nih.gov | ||||
REIT that invests in campuses, multi-tenant spaces and build-to-suit facilities in the US | 1994 | are.com | Pasadena, United States |
Investor details for Encodia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Encodia
11 people are tracked at Encodia (4 in leadership, 5 in board & advisors, 2 in team); the tracked headcount is 85.
| Name | Role | Group |
|---|---|---|
Mark Chee | Co-Founder & President | Leadership |
Nigel Beard | CTO | Leadership |
Li Yu | VP Of Finance | Leadership |
Silvia Gravina | Director, Product Applications & Strategy | Leadership |
David Cruikshank | Partner | Board & advisors |
Michael Weiner | Partner | Board & advisors |
Andrew Elbardissi | Board Member | Board & advisors |
Adam Wieschhaus | Partner | Board & advisors |
Sharon Kedar | Partner | Board & advisors |
Daniel Chang | Senior Information Technology Manager | Team |
Travis Lippert | Staff Program Manager | Team |
Complete people profiles for Encodia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Encodia
3 dated milestones of Encodia across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Encodia is founded.
- Funding First funding round of $223K.
- Funding Latest funding round, Series C, of $75.0M.
Competitors of Encodia
Encodia has 3 listed competitors in our database, 2 of them funded. They include Tierra Biosciences, Amide Technologies and Aquagene.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tierrabiosciences.com | 2015 | Berkeley, United States | $31.56M | 11 | AI-based tools for protein development and custom synthesis are offered. | |
| amidetech.com | 2017 | Cambridge, United States | $16.5M | 8 | Automated peptide synthesis platform is developed with precision reagents. | |
| aquagene.com | 1996 | Alachua, United States | Produces high-quality recombinant proteins for research and industrial applications. |
Detailed competitors of Encodia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Encodia
The website of Encodia (encodia.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 74.5% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Encodia (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Encodia
Complete news archive for Encodia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Encodia
Encodia was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Encodia is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Encodia is a funded company, having raised a total of $75M across 4 funding rounds to date. The company's 1st funding round was a Grant of $222.96K, raised on Jun 2018.
Encodia has 85 employees.
Encodia was founded in 2015 and is based in San Diego, United States. Integrative proteomic analysis is supported through developed technology platforms. Fluidics-based instruments are offered to facilitate automatic multi-step biochemical and chemical processes. Operations focus on the biotechnology sector, with services centered on proteomic tools for research applications. The companys domain is encodia.com.
Encodia's top competitors include Tierra Biosciences, Amide Technologies and Aquagene.
Encodia offers ProteoCode.
Encodia has 10 investors. Key investors include ARE, Arch Venture Partners, Deerfield, Google Ventures, and Decheng Capital.
Encodia operates through Encodia, Inc..
